Myasthenia gravis drugs

These companies make drugs for myasthenia gravis and similar diseases where antibodies attack nerves.
+11.5%
over 6 months · S&P 500 +2.6%

Key indicators

Health
53 / 100
Fragile
Solid
Up over 1 year
6 of 7
Volatility
60%
Calm
Choppy
Profitability
−42%
Low
High
Health and price: against the other tags.